Searched over 200M research papers
10 papers analyzed
These studies suggest ischemic stroke is a complex disorder influenced by genetic, environmental, and lifestyle factors, with significant impacts on morbidity and mortality, and potential for improved outcomes through early intervention, targeted prevention, and novel treatments.
20 papers analyzed
Ischemic stroke is a type of cerebrovascular disease that occurs when a blood vessel supplying blood to the brain is obstructed, leading to brain ischemia and subsequent brain infarction . This blockage can be transient or permanent and is often caused by thrombosis, where a blood clot forms within the blood vessel. The sudden onset of neurological symptoms is directly related to the area of the brain affected by the ischemic event.
The pathophysiology of ischemic stroke involves a complex cascade of biochemical events triggered by the interruption of blood flow. This ischemic cascade leads to neuronal cell death and brain tissue damage. Multiple cell death pathways, including apoptosis, necroptosis, autophagy, and ferroptosis, are implicated in the progression of ischemic stroke. The neurovascular unit (NVU), which includes neurons, glial cells, and blood-brain barrier components, plays a critical role in the pathophysiological and neurovascular repair processes of ischemic stroke.
Ischemic stroke is influenced by a variety of risk factors, both modifiable and non-modifiable. Key modifiable risk factors include high blood pressure, high cholesterol, smoking, high body mass index (BMI), and high plasma glucose levels. Non-modifiable risk factors include age and sex, with aging being the strongest risk factor. Men are more likely to suffer from ischemic stroke earlier in life, while women have a higher incidence and worse outcomes in older age.
Experimental models of ischemic stroke, such as the endovascular suture model in rodents, are used to study the disease's mechanisms and potential treatments. These models help mimic the conditions of human stroke and allow for the investigation of therapeutic interventions like mechanical thrombectomy. However, these models often only cover specific aspects of the disease due to its complex and heterogeneous nature.
The management of acute ischemic stroke focuses on rapid reperfusion to restore blood flow to the affected brain area. This can be achieved pharmacologically with thrombolytic agents or surgically through mechanical thrombectomy. Early recognition and treatment in dedicated stroke centers significantly reduce stroke-related morbidity and mortality. Emerging treatments, such as nanomedicines, aim to improve drug delivery and efficacy while minimizing side effects.
The global burden of ischemic stroke is substantial, with increasing incidence and mortality rates. Between 1990 and 2019, the number of deaths due to ischemic stroke rose from 2.04 million to 3.29 million, and this number is expected to reach 4.90 million by 2030. Effective control of risk factors and targeted preventive strategies are essential to reduce the global disease burden, especially in low socio-demographic index regions.
Ischemic stroke is a major cause of disability and death worldwide, characterized by the sudden blockage of cerebral blood vessels leading to brain damage. Understanding its complex pathophysiology, risk factors, and effective management strategies is crucial for improving patient outcomes. Ongoing research and advancements in treatment approaches, including the use of nanomedicines and targeted therapies, hold promise for better management and reduction of the global burden of ischemic stroke.
Most relevant research papers on this topic